SCHEMBL8429906

SCHEMBL8429906

CC(C)(C)OC(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1CCCl

nearest known ligand 0.34

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.34
ABCB1 P08183 1/20 0.33
PIK3CD O00329 1/20 0.31
FAAH O00519 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
SRC P12931 4/20 0.30
PARP1 P09874 1/20 0.30
ATM Q13315 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9567173 0.89 NR1H2 (0.37) NR1H2ABCB1ALDH1A1CHRM2CHRM1
SCHEMBL17152840 0.88 NR1H2 (0.34) NR1H2ABCB1ALDH1A1CHRM2CHRM1
SCHEMBL8430093 0.88 NR1H2 (0.34) NR1H2ABCB1ALDH1A1CHRM2CHRM1
SCHEMBL12431668 0.87 NR1H2 (0.37) NR1H2ABCB1PIK3CDALDH1A1CHRM2
SCHEMBL4420095 0.87 ABCB1 (0.35) NR1H2ABCB1ALDH1A1CHRM2CHRM1
SCHEMBL8107559 0.87 NR1H2 (0.36) NR1H2ABCB1ALDH1A1CHRM2CHRM1
SCHEMBL4421658 0.87 ABCB1 (0.35) NR1H2ABCB1ALDH1A1CHRM2CHRM1
SCHEMBL9596446 0.87 ABCB1 (0.35) NR1H2ABCB1ALDH1A1CHRM2CHRM1
SCHEMBL4297199 0.87 ABCB1 (0.36) NR1H2ABCB1
SCHEMBL8113817 0.86 NR1H2 (0.36) NR1H2ABCB1ALDH1A1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958817-A1 COMPOSITION CONTAINING DIARYLALKANE DERIVATIVE AS THE ACTIVE INGREDIENT FOR TREATING OR PREVENTING PANCREATITIS SANKYO COMPANY LIMITED (JP) 1999-11-24 EP disclosed
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed